Synlogic Inc

SYBX
1,87
0,01 (0,54%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/3/202412:00GLOBESynlogic Reports Fourth Quarter and Full Year 2023 Financial..
22/2/202422:37EDGAR2Form 8-K - Current report
20/2/202423:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
20/2/202422:06EDGAR2Form 8-K - Current report
20/2/202418:15GLOBESynlogic Adopts Limited Duration Stockholders Rights Plan
16/2/202422:54EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202422:44EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/2/202421:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202422:00EDGAR2Form 8-K - Current report
08/2/202422:15GLOBESynlogic Announces Decision to Discontinue Synpheny-3 Study..
02/2/202418:00GLOBESynlogic Announces Publication of Preclinical and Clinical..
04/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:00GLOBESynlogic Provides Corporate Update and Outlook for 2024
29/12/202322:00EDGAR2Form 8-K - Current report
27/12/202313:00GLOBESynlogic Announces Contract with the Air Force Research Lab
07/12/202313:00GLOBESynlogic Announces Abstract Accepted for Poster Presentation..
17/11/202322:00EDGAR2Form 8-K - Current report
15/11/202301:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202301:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202301:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:00GLOBESynlogic Reports Third Quarter 2023 Financial Results and..
09/11/202312:44EDGAR2Form 8-K - Current report
09/11/202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:00GLOBESynlogic Achieves Research Milestone and Earns $2.5 Million..
07/11/202312:45EDGAR2Form 8-K - Current report
13/10/202322:17EDGAR2Form SC 13D/A - General statement of acquisition of..
03/10/202322:15GLOBESynlogic Announces Closing of $21.0 Million Underwritten..
02/10/202323:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/9/202314:53EDGAR2Form 8-K - Current report
29/9/202313:00GLOBESynlogic Announces Pricing of $21.0 Million Underwritten..
29/9/202303:43EDGAR2Form S-1MEF - Registration adding securities to prior Form..
28/9/202322:15EDGAR2Form 8-K - Current report
28/9/202317:15GLOBESynlogic Announces Publication of Synpheny-1 Phase 2 Study..
28/9/202314:39EDGAR2Form S-1/A - General form for registration of securities..
27/9/202318:30GLOBESynlogic Announces Reverse Stock Split
27/9/202303:41EDGAR2Form S-1/A - General form for registration of securities..
22/9/202322:15EDGAR2Form 8-K - Current report
21/9/202313:00GLOBESynlogic to Participate in Chardan’s Genetic Medicines..
19/9/202317:00GLOBESynlogic Announces CEO Aoife Brennan Named to PharmaVoice..
08/9/202322:06EDGAR2Form S-1 - General form for registration of securities under..
01/9/202314:00EDGAR2Form DEF 14A - Other definitive proxy statements
21/8/202323:15EDGAR2Form PRE 14A - Other preliminary proxy statements
16/8/202322:05EDGAR2Form 8-K - Current report
10/8/202313:00GLOBESynlogic Reports Second Quarter 2023 Financial Results and..
10/8/202312:35EDGAR2Form 8-K - Current report
10/8/202312:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/7/202313:00GLOBESynlogic Granted Fast Track Designation from FDA for..
28/6/202313:00GLOBESynlogic Announces International Nonproprietary Name..
27/6/202313:00GLOBESynlogic Announces Participation in SVB Securities..
08/6/202312:45GLOBESynlogic Reminds Stockholders of 2023 Annual General Meeting..
Apertura: 1,87 Min: 1,84 Max: 1,88
Chiusura: 1,86

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network